STAT4-IN-1 is a STAT4 inhibitor with a Ki of 0.35 µM. It holds promise for research into autoimmune diseases, including inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, and diabetes.
Target:
STAT
* VAT and and shipping costs not included. Errors and price changes excepted
